250 related articles for article (PubMed ID: 10500157)
1. Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element.
Sabbah M; Courilleau D; Mester J; Redeuilh G
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11217-22. PubMed ID: 10500157
[TBL] [Abstract][Full Text] [Related]
2. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells.
Lee RJ; Albanese C; Stenger RJ; Watanabe G; Inghirami G; Haines GK; Webster M; Muller WJ; Brugge JS; Davis RJ; Pestell RG
J Biol Chem; 1999 Mar; 274(11):7341-50. PubMed ID: 10066798
[TBL] [Abstract][Full Text] [Related]
3. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter.
Cicatiello L; Addeo R; Sasso A; Altucci L; Petrizzi VB; Borgo R; Cancemi M; Caporali S; Caristi S; Scafoglio C; Teti D; Bresciani F; Perillo B; Weisz A
Mol Cell Biol; 2004 Aug; 24(16):7260-74. PubMed ID: 15282324
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel DNA regulatory element in the rabbit surfactant protein B (SP-B) promoter that is a target for ATF/CREB and AP-1 transcription factors.
Berhane K; Boggaram V
Gene; 2001 May; 268(1-2):141-51. PubMed ID: 11368910
[TBL] [Abstract][Full Text] [Related]
5. Activating transcription factor 2 targets c-Fos, but not c-Jun, in growth plate chondrocytes.
Li X; LuValle P
J Cell Biochem; 2011 Jan; 112(1):211-6. PubMed ID: 21069729
[TBL] [Abstract][Full Text] [Related]
6. Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes.
Beier F; Lee RJ; Taylor AC; Pestell RG; LuValle P
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1433-8. PubMed ID: 9990041
[TBL] [Abstract][Full Text] [Related]
7. Activation of cyclin D1 by estradiol and spermine in MCF-7 breast cancer cells: a mechanism involving the p38 MAP kinase and phosphorylation of ATF-2.
Lewis JS; Vijayanathan V; Thomas TJ; Pestell RG; Albanese C; Gallo MA; Thomas T
Oncol Res; 2005; 15(3):113-28. PubMed ID: 16050133
[TBL] [Abstract][Full Text] [Related]
8. Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements.
Castro-Rivera E; Samudio I; Safe S
J Biol Chem; 2001 Aug; 276(33):30853-61. PubMed ID: 11410592
[TBL] [Abstract][Full Text] [Related]
9. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.
D'Amico M; Hulit J; Amanatullah DF; Zafonte BT; Albanese C; Bouzahzah B; Fu M; Augenlicht LH; Donehower LA; Takemaru K; Moon RT; Davis R; Lisanti MP; Shtutman M; Zhurinsky J; Ben-Ze'ev A; Troussard AA; Dedhar S; Pestell RG
J Biol Chem; 2000 Oct; 275(42):32649-57. PubMed ID: 10915780
[TBL] [Abstract][Full Text] [Related]
10. Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4.
Shimizu M; Nomura Y; Suzuki H; Ichikawa E; Takeuchi A; Suzuki M; Nakamura T; Nakajima T; Oda K
Exp Cell Res; 1998 Feb; 239(1):93-103. PubMed ID: 9511728
[TBL] [Abstract][Full Text] [Related]
11. Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells: involvement of cAMP-responsive element.
Kim MJ; Kang JH; Park YG; Ryu GR; Ko SH; Jeong IK; Koh KH; Rhie DJ; Yoon SH; Hahn SJ; Kim MS; Jo YH
J Endocrinol; 2006 Mar; 188(3):623-33. PubMed ID: 16522741
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of 16alpha-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells.
Lewis JS; Thomas TJ; Pestell RG; Albanese C; Gallo MA; Thomas T
J Mol Endocrinol; 2005 Feb; 34(1):91-105. PubMed ID: 15691880
[TBL] [Abstract][Full Text] [Related]
13. Transactivation of the ApoCIII promoter by ATF-2 and repression by members of the Jun family.
Hadzopoulou-Cladaras M; Lavrentiadou SN; Zannis VI; Kardassis D
Biochemistry; 1998 Oct; 37(40):14078-87. PubMed ID: 9760243
[TBL] [Abstract][Full Text] [Related]
14. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression.
Liu MM; Albanese C; Anderson CM; Hilty K; Webb P; Uht RM; Price RH; Pestell RG; Kushner PJ
J Biol Chem; 2002 Jul; 277(27):24353-60. PubMed ID: 11986316
[TBL] [Abstract][Full Text] [Related]
15. Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation.
Falvo JV; Parekh BS; Lin CH; Fraenkel E; Maniatis T
Mol Cell Biol; 2000 Jul; 20(13):4814-25. PubMed ID: 10848607
[TBL] [Abstract][Full Text] [Related]
16. ATF and Jun transcription factors, acting through an Ets/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic Mono Mac 6 cells.
Boehlk S; Fessele S; Mojaat A; Miyamoto NG; Werner T; Nelson EL; Schlöndorff D; Nelson PJ
Eur J Immunol; 2000 Apr; 30(4):1102-12. PubMed ID: 10760799
[TBL] [Abstract][Full Text] [Related]
17. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.
Sjöblom A; Yang W; Palmqvist L; Jansson A; Rymo L
J Virol; 1998 Feb; 72(2):1365-76. PubMed ID: 9445037
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence.
Shiozawa T; Miyamoto T; Kashima H; Nakayama K; Nikaido T; Konishi I
Oncogene; 2004 Nov; 23(53):8603-10. PubMed ID: 15467760
[TBL] [Abstract][Full Text] [Related]
19. Activating transcription factor 2 is necessary for maximal activity and serum induction of the cyclin A promoter in chondrocytes.
Beier F; Taylor AC; LuValle P
J Biol Chem; 2000 Apr; 275(17):12948-53. PubMed ID: 10777595
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors.
Papassava P; Gorgoulis VG; Papaevangeliou D; Vlahopoulos S; van Dam H; Zoumpourlis V
Cancer Res; 2004 Dec; 64(23):8573-84. PubMed ID: 15574764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
